Insulet (PODD) shares plummeted 5.06% during intraday trading on Thursday, reflecting significant selling pressure.

The sharp decline follows a series of analyst price target cuts from multiple firms after the company's fourth-quarter results. Citigroup, Oppenheimer, JPMorgan, Raymond James, Bernstein, and Truist Securities all reduced their targets, citing the quarterly performance.

While most analysts maintained positive ratings such as Buy or Outperform, the downward revisions to price targets indicate revised expectations and contributed to negative investor sentiment during the session.